Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Melanie Davies and Kamlesh Khunti.
Melanie Davies
Connection Strength
14.731
Kamlesh Khunti
  1. Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes? Diabetes Obes Metab. 2019 02; 21(2):207-209.
    View in: PubMed
    Score: 0.789
  2. Do sulphonylureas still have a place in clinical practice? Lancet Diabetes Endocrinol. 2018 10; 6(10):821-832.
    View in: PubMed
    Score: 0.757
  3. Clinical inertia versus overtreatment in glycaemic management. Lancet Diabetes Endocrinol. 2018 04; 6(4):266-268.
    View in: PubMed
    Score: 0.737
  4. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017 11; 40(11):1588-1596.
    View in: PubMed
    Score: 0.729
  5. Clinical inertia-Time to reappraise the terminology? Prim Care Diabetes. 2017 04; 11(2):105-106.
    View in: PubMed
    Score: 0.705
  6. Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort. BMC Infect Dis. 2021 Jul 31; 21(1):717.
    View in: PubMed
    Score: 0.240
  7. Long COVID - metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021 07; 17(7):379-380.
    View in: PubMed
    Score: 0.238
  8. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort. Obesity (Silver Spring). 2021 07; 29(7):1223-1230.
    View in: PubMed
    Score: 0.236
  9. Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank. Int J Obes (Lond). 2021 05; 45(5):1155-1159.
    View in: PubMed
    Score: 0.233
  10. COVID-19, ethnicity and cardiometabolic disease self-management in UK primary care. Diabetes Metab Syndr. 2020 Nov-Dec; 14(6):2241-2243.
    View in: PubMed
    Score: 0.229
  11. The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis. Endocrinol Diabetes Metab. 2020 Aug 14; e00176.
    View in: PubMed
    Score: 0.224
  12. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020 10; 22(10):1915-1924.
    View in: PubMed
    Score: 0.223
  13. COVID-19 cumulative mortality rates for frontline healthcare staff in England. Br J Gen Pract. 2020 Jul; 70(696):327-328.
    View in: PubMed
    Score: 0.222
  14. Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):965-967.
    View in: PubMed
    Score: 0.222
  15. Multimorbidity and SARS-CoV-2 infection in UK Biobank. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):775-776.
    View in: PubMed
    Score: 0.221
  16. Obesity and risk of COVID-19: analysis of UK biobank. Prim Care Diabetes. 2020 10; 14(5):566-567.
    View in: PubMed
    Score: 0.221
  17. Impact of Depression and Anxiety on Change to Physical Activity Following a Pragmatic Diabetes Prevention Program Within Primary Care: Pooled Analysis From Two Randomized Controlled Trials. Diabetes Care. 2019 10; 42(10):1847-1853.
    View in: PubMed
    Score: 0.209
  18. Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational Study. Exp Clin Endocrinol Diabetes. 2021 Jun; 129(6):413-419.
    View in: PubMed
    Score: 0.206
  19. Corrections to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs. 2019 04; 79(6):685.
    View in: PubMed
    Score: 0.204
  20. Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs. 2019 Feb; 79(2):173-186.
    View in: PubMed
    Score: 0.202
  21. Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs. 2019 02; 79(2):187.
    View in: PubMed
    Score: 0.202
  22. Baby Steps - a structured group education programme with accompanying mobile web application designed to promote physical activity in women with a history of gestational diabetes: study protocol for a randomised controlled trial. Trials. 2018 Dec 12; 19(1):682.
    View in: PubMed
    Score: 0.200
  23. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. Liver Int. 2019 03; 39(3):557-567.
    View in: PubMed
    Score: 0.200
  24. Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis. Acta Diabetol. 2019 Mar; 56(3):331-339.
    View in: PubMed
    Score: 0.199
  25. The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 12; 7(11):e11289.
    View in: PubMed
    Score: 0.199
  26. Movement through Active Personalised engagement (MAP) - a self-management programme designed to promote physical activity in people with multimorbidity: study protocol for a randomised controlled trial. Trials. 2018 Oct 20; 19(1):576.
    View in: PubMed
    Score: 0.198
  27. Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Pract. 2018 Dec; 146:76-84.
    View in: PubMed
    Score: 0.197
  28. Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide study. J Diabetes. 2019 Apr; 11(4):265-272.
    View in: PubMed
    Score: 0.197
  29. Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial. Trials. 2018 Oct 04; 19(1):537.
    View in: PubMed
    Score: 0.197
  30. The General Practitioner Prompt Study to Reduce Cardiovascular and Renal Complications in Patients With Type 2 Diabetes and Renal Complications: Protocol and Baseline Characteristics for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2018 Jun 08; 7(6):e152.
    View in: PubMed
    Score: 0.193
  31. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2018 09; 20(9):2169-2178.
    View in: PubMed
    Score: 0.193
  32. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia. 2018 07; 61(7):1592-1602.
    View in: PubMed
    Score: 0.191
  33. Type 2 diabetes - Authors' reply. Lancet. 2018 03 31; 391(10127):1262.
    View in: PubMed
    Score: 0.190
  34. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2018 04; 271:223-231.
    View in: PubMed
    Score: 0.189
  35. What have we learnt from "real world" data, observational studies and meta-analyses. Diabetes Obes Metab. 2018 02; 20 Suppl 1:47-58.
    View in: PubMed
    Score: 0.188
  36. Technology and chronic disease management - Authors' reply. Lancet Diabetes Endocrinol. 2018 02; 6(2):91-92.
    View in: PubMed
    Score: 0.188
  37. Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk. Am J Cardiovasc Drugs. 2018 Feb; 18(1):13-24.
    View in: PubMed
    Score: 0.188
  38. The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women. PLoS One. 2017; 12(11):e0187448.
    View in: PubMed
    Score: 0.186
  39. Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study. Eur Heart J. 2017 Nov 14; 38(43):3232-3240.
    View in: PubMed
    Score: 0.185
  40. Structured education programme for women with polycystic ovary syndrome: a randomised controlled trial. Endocr Connect. 2018 Jan; 7(1):26-35.
    View in: PubMed
    Score: 0.185
  41. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017 Oct 16; 7(10):e016358.
    View in: PubMed
    Score: 0.184
  42. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018 02; 6(2):130-142.
    View in: PubMed
    Score: 0.184
  43. Comment on: "Strengths and Limitations of Healthcare Databases in the Evaluation of Hypoglycaemia". Diabetes Obes Metab. 2017 10; 19(10):1495-1496.
    View in: PubMed
    Score: 0.181
  44. Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control. Prim Care Diabetes. 2017 10; 11(5):414-420.
    View in: PubMed
    Score: 0.181
  45. Associations Between Anthropometric Measurements and Cardiometabolic Risk Factors in White European and South Asian Adults in the United Kingdom. Mayo Clin Proc. 2017 06; 92(6):925-933.
    View in: PubMed
    Score: 0.180
  46. Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England. Diabetes Obes Metab. 2017 10; 19(10):1371-1378.
    View in: PubMed
    Score: 0.178
  47. Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross-sectional analysis of the 2008 Health Survey for England. BMJ Open. 2017 04 03; 7(4):e014456.
    View in: PubMed
    Score: 0.178
  48. Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation. Diabetologia. 2017 06; 60(6):1007-1015.
    View in: PubMed
    Score: 0.177
  49. Type 2 diabetes. Lancet. 2017 Jun 03; 389(10085):2239-2251.
    View in: PubMed
    Score: 0.176
  50. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations. Postgrad Med J. 2017 May; 93(1099):289-294.
    View in: PubMed
    Score: 0.176
  51. Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT. BMC Public Health. 2017 01 14; 17(1):80.
    View in: PubMed
    Score: 0.175
  52. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2015 Feb; 38(2):316-22.
    View in: PubMed
    Score: 0.151
  53. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Res Clin Pract. 2011 Aug; 93(2):292-294.
    View in: PubMed
    Score: 0.118
  54. Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5(6):997-1007.
    View in: PubMed
    Score: 0.060
  55. Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation. Eur J Public Health. 2021 07 13; 31(3):630-634.
    View in: PubMed
    Score: 0.060
  56. The impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in individuals with type 2 diabetes. Diabet Med. 2021 10; 38(10):e14549.
    View in: PubMed
    Score: 0.058
  57. Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic. Diabet Med. 2021 03; 38(3):e14469.
    View in: PubMed
    Score: 0.058
  58. Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study. Mayo Clin Proc. 2021 01; 96(1):156-164.
    View in: PubMed
    Score: 0.057
  59. Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study. EClinicalMedicine. 2020 Aug; 25:100466.
    View in: PubMed
    Score: 0.056
  60. Body mass index and the risk of COVID-19 across ethnic groups: Analysis of UK Biobank. Diabetes Obes Metab. 2020 10; 22(10):1953-1954.
    View in: PubMed
    Score: 0.056
  61. 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. 2019 08; 4(8):e406-e420.
    View in: PubMed
    Score: 0.052
  62. A fitting problem: Standardising shoe fit standards to reduce related diabetic foot ulcers. Diabetes Res Clin Pract. 2019 Aug; 154:66-74.
    View in: PubMed
    Score: 0.052
  63. Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol. 2019 Aug; 56(8):839-850.
    View in: PubMed
    Score: 0.051
  64. Differences in objectively measured physical activity and sedentary behaviour between white Europeans and south Asians recruited from primary care: cross-sectional analysis of the PROPELS trial. BMC Public Health. 2019 Jan 21; 19(1):95.
    View in: PubMed
    Score: 0.050
  65. Postpartum monitoring of women with a history of gestational diabetes - A cross-sectional study of an inner-city population. Prim Care Diabetes. 2019 08; 13(4):376-379.
    View in: PubMed
    Score: 0.050
  66. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol. BMJ Open. 2018 11 08; 8(11):e023206.
    View in: PubMed
    Score: 0.050
  67. Associations of Physical Behaviours and Behavioural Reallocations with Markers of Metabolic Health: A Compositional Data Analysis. Int J Environ Res Public Health. 2018 10 17; 15(10).
    View in: PubMed
    Score: 0.049
  68. Online patient education interventions in type 2 diabetes or cardiovascular disease: A systematic review of systematic reviews. Prim Care Diabetes. 2019 02; 13(1):16-27.
    View in: PubMed
    Score: 0.049
  69. Compliance of Adolescent Girls to Repeated Deployments of Wrist-Worn Accelerometers. Med Sci Sports Exerc. 2018 07; 50(7):1508-1517.
    View in: PubMed
    Score: 0.048
  70. Beyond Cut Points: Accelerometer Metrics that Capture the Physical Activity Profile. Med Sci Sports Exerc. 2018 06; 50(6):1323-1332.
    View in: PubMed
    Score: 0.048
  71. Effectiveness of the 'Girls Active' school-based physical activity programme: A cluster randomised controlled trial. Int J Behav Nutr Phys Act. 2018 04 25; 15(1):40.
    View in: PubMed
    Score: 0.048
  72. Associations Between Sedentary Behaviors and Cognitive Function: Cross-Sectional and Prospective Findings From the UK Biobank. Am J Epidemiol. 2018 03 01; 187(3):441-454.
    View in: PubMed
    Score: 0.047
  73. Accelerometer-assessed Physical Activity in Epidemiology: Are Monitors Equivalent? Med Sci Sports Exerc. 2018 02; 50(2):257-265.
    View in: PubMed
    Score: 0.047
  74. Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018 04; 20(4):985-997.
    View in: PubMed
    Score: 0.047
  75. Sedentary Time and MRI-Derived Measures of Adiposity in Active Versus Inactive Individuals. Obesity (Silver Spring). 2018 01; 26(1):29-36.
    View in: PubMed
    Score: 0.047
  76. Associations of Physical Activity Intensities with Markers of Insulin Sensitivity. Med Sci Sports Exerc. 2017 Dec; 49(12):2451-2458.
    View in: PubMed
    Score: 0.047
  77. Reallocating sitting time to standing or stepping through isotemporal analysis: associations with markers of chronic low-grade inflammation. J Sports Sci. 2018 Jul; 36(14):1586-1593.
    View in: PubMed
    Score: 0.046
  78. Fitness Moderates Glycemic Responses to Sitting and Light Activity Breaks. Med Sci Sports Exerc. 2017 Nov; 49(11):2216-2222.
    View in: PubMed
    Score: 0.046
  79. Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: A randomized crossover trial. Diabetes Obes Metab. 2017 12; 19(12):1732-1739.
    View in: PubMed
    Score: 0.045
  80. Change in Sedentary Time, Physical Activity, Bodyweight, and HbA1c in High-Risk Adults. Med Sci Sports Exerc. 2017 06; 49(6):1120-1125.
    View in: PubMed
    Score: 0.045
  81. Understanding and supporting women with polycystic ovary syndrome: a qualitative study in an ethnically diverse UK sample. Endocr Connect. 2017 Jul; 6(5):323-330.
    View in: PubMed
    Score: 0.045
  82. The association between air pollution and type 2 diabetes in a large cross-sectional study in Leicester: The CHAMPIONS Study. Environ Int. 2017 07; 104:41-47.
    View in: PubMed
    Score: 0.045
  83. Associations of objectively measured moderate-to-vigorous-intensity physical activity and sedentary time with all-cause mortality in a population of adults at high risk of type 2 diabetes mellitus. Prev Med Rep. 2017 Mar; 5:285-288.
    View in: PubMed
    Score: 0.044
  84. Associations of reallocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: a cross-sectional analysis of adults at risk of type 2 diabetes. BMJ Open. 2017 01 13; 7(1):e014267.
    View in: PubMed
    Score: 0.044
  85. A cluster randomized controlled trial of the effectiveness and cost-effectiveness of intermediate care clinics for diabetes (ICCD): study protocol for a randomized controlled trial. Trials. 2012 Sep 12; 13:164.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.